Boston Life, Greenwich Pharmaceuticals Inc. deal

In earlier development are a cancer amplification system for reducing the side effects of chemotherapy and radiotherapy, and an intracellular regulator of the transcription factor that controls the expression of MHC class 2 molecules for autoimmune diseases. ...